DLA Piper Names Pollard Co-Chair of FDA Practice in Washington

Feb. 1, 2024, 7:47 PM UTC

Vernessa Pollard has joined DLA Piper as a partner and co-chair of the FDA practice in Washington, D.C., the firm said Thursday.

Pollard represents life sciences, medical device, and technology companies through FDA regulatory complexities to bring technologies and products to market, according to DLA Piper.

She served as associate chief counsel for enforcement in the Office of Chief Counsel of the FDA, said the firm.

This story was produced by Bloomberg Law Automation.


To contact Bloomberg Law Automation: automation@bloombergindustry.com

To contact the editors responsible for this story: Kiera Geraghty at kgeraghty@bloombergindustry.com; Ashara Wilson at awilson1@bloombergindustry.com

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.